why did fda stop tirzepatide Announces End To Compounded By March 19, 2025 FDA Drops Latest Statement: Tirzepatide
Description
Additional symptoms may include night sweats, fatigue, and loss of appetite

Jay Michael Snow is a board-certified bariatric surgeon and Fellow of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery

When youre sleep deprived, research has shown that release of post-meal GLP-1 is delayed, which keeps you from feeling full when you should
Tirzepatide is dosed carefully by your provider to minimize side effects while maximizing benefit

Bottom Line Tirzepatide does not directly cause B12 deficiency, but reduced food intake, slower digestion, and common pairing with metformin can all put your B12 levels at risk over time
